Seeing Is Believing
THRX is currently covered by 4 analysts with an average price target of $13.06. This is a potential upside of $9 (221.67%) from yesterday's end of day stock price of $4.06.
Theseus Pharmaceuticals's activity chart (see below) currently has 1 price targets and 15 ratings on display. The stock rating distribution of THRX is 85.71% BUY and 14.29% HOLD.
Highest price target for THRX is $9, Lowest price target is $7, average price target is $13.06.
Most recent stock forecast was given by AMI FADIA from NEEDHAM on 14-Jul-2023. First documented stock forecast 02-Nov-2021.
Currently out of the existing stock ratings of THRX, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
23
9 months 3 days ago
0/5 (0%)
$15.26 (197.16%)
Buy
9
$4.94 (121.67%)
22
9 months 3 days ago
0/5 (0%)
$6.34 (238.35%)
Buy
7
$2.94 (72.41%)
24
9 months 3 days ago
0/2 (0%)
$4.34 (163.16%)
Buy
7
$2.95 (72.84%)
25
9 months 4 days ago
0/2 (0%)
$4.34 (163.16%)
Hold
24
10 months 25 days ago
0/1 (0%)
$16.2 (207.69%)
What is THRX (Theseus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on THRX (Theseus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on THRX (Theseus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on THRX (Theseus Pharmaceuticals)?
Which analyst is the currently most bullish on THRX (Theseus Pharmaceuticals)?
Which analyst is the currently most reserved on THRX (Theseus Pharmaceuticals)?